Alphabet Replaces Verizon in Dow Jones Industrial Average 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
WILMINGTON, Del., Feb. 19, 2016 -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)?
- Did you purchase your shares between May 17, 2013 and December 28, 2015, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. reminds shareholders of Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ:AVXL) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. A complaint was filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the common stock of Anavex between May 17, 2013 and December 28, 2015, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you wish to serve as lead plaintiff, you must move the Court no later than February 29, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you purchased shares of Anavex during the Class Period, or purchased shares prior to the Class Period and still hold Anavex, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/anavex-life-sciences-corp-avxl.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com
